Pages that link to "Q45026021"
Jump to navigation
Jump to search
The following pages link to Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens (Q45026021):
Displaying 10 items.
- Combining antihypertensive and antihyperlipidemic agents - optimizing cardiovascular risk factor management (Q35602493) (← links)
- Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: effectiveness in combination with diuretics or beta-blockers for treating hypertension (Q36536160) (← links)
- Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin (Q36536199) (← links)
- Review: use of electronic medical records for health outcomes research: a literature review (Q37412856) (← links)
- Atorvastatin calcium plus amlodipine for the treatment of hypertension. (Q38058827) (← links)
- Amlodipine/atorvastatin single pill for the management of hypertensive patients with additional cardiovascular risk factors (Q40347884) (← links)
- Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial. (Q45931826) (← links)
- Amlodipine reduces predicted risk of coronary heart disease in high-risk patients with hypertension in Spain (The CORONARIA Study). (Q46191450) (← links)
- Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control (Q51579351) (← links)
- Cardiovascular risk profile in individuals initiating treatment for overactive bladder - Challenges and learnings for comparative analysis using linked claims and electronic medical record databases (Q57459889) (← links)